366
Views
10
CrossRef citations to date
0
Altmetric
Drug Evaluations

Anacetrapib for the treatment of dyslipidaemia: the last bastion of the cholesteryl ester transfer protein inhibitors?

, &
Pages 275-281 | Received 26 Oct 2015, Accepted 04 Dec 2015, Published online: 28 Dec 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Cristina Saavedra, Jorge Barriuso, Mairéad G McNamara, Juan W Valle & Angela Lamarca. (2019) Spotlight on telotristat ethyl for the treatment of carcinoid syndrome diarrhea: patient selection and reported outcomes. Cancer Management and Research 11, pages 7537-7556.
Read now
Arrigo F.G. Cicero, Marilisa Bove & Claudio Borghi. (2018) Pharmacokinetics, pharmacodynamics and clinical efficacy of non-statin treatments for hypercholesterolemia. Expert Opinion on Drug Metabolism & Toxicology 14:1, pages 9-15.
Read now
Gerald H. Tomkin & Daphne Owens. (2017) Investigational therapies for hypercholesterolemia. Expert Opinion on Investigational Drugs 26:5, pages 603-617.
Read now
Claudio Borghi & Arrigo F. G. Cicero. (2017) Pharmacokinetic drug evaluation of anacetrapib for the treatment of dyslipidemia. Expert Opinion on Drug Metabolism & Toxicology 13:2, pages 205-209.
Read now
Matteo Lambertini, Maria Carolina Pescio, Giulia Viglietti, Oranite Goldrat, Lucia Del Mastro, Paola Anserini & Isabelle Demeestere. (2017) Methods of controlled ovarian stimulation for embryo/oocyte cryopreservation in breast cancer patients. Expert Review of Quality of Life in Cancer Care 2:1, pages 47-59.
Read now

Articles from other publishers (5)

Matteo Pirro, Biagio Ricciuti, Daniel J. Rader, Alberico L. Catapano, Amirhossein Sahebkar & Maciej Banach. (2018) High density lipoprotein cholesterol and cancer: Marker or causative?. Progress in Lipid Research 71, pages 54-69.
Crossref
Michael M. Page & Gerald F. Watts. (2017) PCSK 9 in context: A contemporary review of an important biological target for the prevention and treatment of atherosclerotic cardiovascular disease . Diabetes, Obesity and Metabolism 20:2, pages 270-282.
Crossref
Reema Abu Khalaf, Dima Sabbah, Eveen Al-Shalabi, Samar Bishtawi, Ghadeer Albadawi & Ghassan Abu Sheikha. (2017) Synthesis, Biological Evaluation, and Molecular Modeling Study of Substituted Benzyl Benzamides as CETP Inhibitors. Archiv der Pharmazie 350:12, pages 1700204.
Crossref
G. Kees Hovingh, Anne C. Goldberg & Patrick M. Moriarty. (2017) Managing the challenging homozygous familial hypercholesterolemia patient: Academic insights and practical approaches for a severe dyslipidemia, a National Lipid Association Masters Summit. Journal of Clinical Lipidology 11:3, pages 602-616.
Crossref
Yu Kataoka, Jordan Andres, Rishi Puri, Peter Psaltis & Stephen J. Nicholls. (2016) Additional Lipid Targets to Modulate Atherosclerotic Plaques beyond LDL-C Lowering. Journal of the Japanese Coronary Association 22:4, pages 217-227.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.